Loading…
← CockpitCompetitor Analysis › 002876.SZ Shenzhen Sunnypol Optoelectornics Co. Ltd. Class AOpen in the cockpit ↗

Shenzhen Sunnypol Optoelectornics Co. Ltd. Class A002876.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties
Momentum leader 82
Mkt cap
$728M
US dollars, full cap
Free float
73%
of shares outstanding
$/day
$24.1M
20-day average traded
Fwd P/E
41.8×
forward earnings
ROIC−WACC
-2.4 pp
WACC 8.8%
Hurdle
-3 pp
Req g minus delivered
Next earnings
126 days
12 Mar 2027
Close · CNYCN¥28.41
1D-5.4%
1W+13.6%
1M-5.8%
3M+9.1%
6M-8.1%
YTD+18.7%
1Y+19.4%
ATR %6.2%
52w lowhigh20.1% off high

What Shenzhen Sunnypol Optoelectornics does

Employees: 3,611

Shenzhen Sunnypol Optoelectornics at a glance

Size Shenzhen Sunnypol Optoelectornics (002876.SZ) is a China Health Care company (Medical Specialties) with a market value of $728M, the 2982nd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥28.41 on 6 Nov 2026.

Performance Over six months the shares fell 8.1%, against -8.7% for the median peer and -16.4% for the China market (cap-weighted) — 11th highest of 21 in its peer set.

Growth Revenue grew 29.4% over the last twelve months (peer median +5.9%); the operating margin is 4.6% (peer median 13.7%).

Valuation It trades at 41.8× forward earnings against a peer median of 19.5× (3rd most expensive of 17).

Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -3 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.4 points below its cost of capital (8.8% WACC).

Next results Next results expected around 12 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026002876.SZ 92Peer median 92
Six months, rebased to 100: Shenzhen Sunnypol Optoelectornics against the median of its 20 peers (local-currency closes).

Shenzhen Sunnypol Optoelectornics financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥4.35BCN¥3.68BCN¥2.58BCN¥2.06BCN¥2.17B
Revenue growth—+43%+25%-5%—
Gross profitCN¥922MCN¥540MCN¥418MCN¥283MCN¥450M
EBITDAn/aCN¥376MCN¥261MCN¥165MCN¥344M
Net incomeCN¥122MCN¥47.1MCN¥68.1MCN¥42.8MCN¥206M
Free cash flowCN¥346M-CN¥157M-CN¥438M-CN¥630MCN¥164M
Capital expenditureCN¥144MCN¥350MCN¥481MCN¥679MCN¥252M
Total debtCN¥2.58BCN¥2.59BCN¥1.82BCN¥1.24BCN¥965M

Quarterly statements and history in the cockpit →

Shenzhen Sunnypol Optoelectornics competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%+60%-10%0%+10%QDEL688410MLAB300453SNT688389301234491000300622PACBCTKB688085300326INMD7575688236300952301367VREX1501002876.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Shenzhen Sunnypol Optoelectornics is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%20×40×QDEL688410MLAB300453SNT688389300622688085300326INMD7575688236300952301367VREX1501002876.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shenzhen Sunnypol Optoelectornics is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%688410MLAB300453SNT688389301234300622688085300326INMD75756882363013671501002876.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Shenzhen Sunnypol Optoelectornics is the large dot.

Shenzhen Sunnypol Optoelectornics competitors and peer comparison

How Shenzhen Sunnypol Optoelectornics compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shenzhen Sunnypol Optoelectornics against its 20 peers (data as of 6 Nov 2026)
Measure002876.SZPeer medianRank in peer set
1-month return-5.8%+0.5%5th lowest of 21
6-month return-8.1%-8.7%11th highest of 21
Distance from 52-week high-20.1%-24.9%11th highest of 21
Revenue growth (TTM)+29.4%+5.9%6th highest of 21
Operating margin4.6%13.7%7th lowest of 21
Forward P/E41.8×19.5×3rd most expensive of 17
Growth the price implies (Req g, 7 yrs)11.1%0.1%6th most demanding of 15
Growth delivered (Del g)+14.2%+12.8%6th highest of 15
Hurdle (Req g minus delivered)-3.1 pp-10.9 pp6th most demanding of 15
ROIC minus cost of capital-2.4 pp+3.9 pp7th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Shenzhen Sunnypol Optoelectornics 002876.SZChina$728M-8%+29%5%41.8×11.1%+14.2%
QuidelOrtho QDELUnited States$734M-1%-5%-2%12.0×n/an/a
SWS Hemodialysis Care 688410.SSChina$723M-12%+31%19%24.1×16.7%+25.9%
Mesa Laboratories MLABUnited States$718M+23%+3%9%12.6×21.1%+13.2%
Jiang Xi Sanxin Medtec 300453.SZChina$741M-5%+12%18%16.1×-2.1%+11.8%
Synektik SNT.WAPoland$713M+16%+50%24%11.8×0.1%+40.3%
Shenzhen Lifotronic Technology 688389.SSChina$749M-11%+14%13%32.4×13.5%+13.3%
Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZChina$750M+177%-14%3%n/a33.5%-0.6%
Livsmed 491000.KSSouth Korea$706M-47%+89%-59%n/an/an/a
Doctorglasses Chain 300622.SZChina$757M-10%+6%14%24.5×-2.4%+15.7%
Pacific Biosciences of California PACBUnited States$701M+60%+2%-102%n/an/an/a
Cytek Biosciences CTKBUnited States$758M+26%+5%-22%n/an/an/a
Shanghai Sanyou Medical 688085.SSChina$700M-21%+15%4%50.9×29.1%+6.8%
Shanghai Kinetic Medical 300326.SZChina$698M-7%-28%17%27.4×8.1%-1.9%
InMode INMDUnited States$767M-5%-7%18%10.1×-10.5%+12.4%
Japan Lifeline 7575.TJapan$685M+16%+6%19%14.1×-9.7%+2.9%
Beijing Chunlizhengda Medical Instruments 688236.SSChina$684M-21%-13%31%19.1×-5.4%+2.2%
Jiangsu Hanvo Safety Product 300952.SZChina$681M-21%+6%8%47.6×n/an/a
BMC Medical 301367.SZChina$780M-13%+37%17%19.8×0.1%+15.6%
Varex Imaging VREXUnited States$783M-10%+5%8%20.3×n/an/a
Shanghai INT Medical Instruments 1501.HKHong Kong$784M-25%+35%21%17.8×-2.1%+23.5%

Questions

Which companies are Shenzhen Sunnypol Optoelectornics's closest peers?
The cockpit's peer set: QuidelOrtho (QDEL), SWS Hemodialysis Care (688410.SS), Mesa Laboratories (MLAB), Jiang Xi Sanxin Medtec (300453.SZ), Synektik (SNT.WA), Shenzhen Lifotronic Technology (688389.SS), Anhui Hongyu Wuzhou Medical Manufacturer (301234.SZ), Livsmed (491000.KS).
Is Shenzhen Sunnypol Optoelectornics expensive compared with its peers?
On forward p/e it trades at 41.8× against a peer median of 19.5×, 3rd most expensive of 17 in its peer set. For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -3 pp: the price already allows for a slowdown.
How has Shenzhen Sunnypol Optoelectornics stock performed?
Over six months to 6 Nov 2026 the shares returned -8.1% against -8.7% for the median peer; over one year +19.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.